HOUSTON,March 21, 2024(GLOBE NEWSWIRE) --Intuitive Machines, Inc.(Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space exploration, infrastructure, and services company, today announced its financial results for the fourth quarter and full year endedDecember ...
Some of the statements contained in this press release constitute forward-looking statements within the meaning of the federal securities laws. Any forward-looking statements contained in this press release are intended to be made pursuant to the safe harbor provisions of Section 21E of...
offering does not constitute a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regul...
Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today provided corporate updates and reported its financial results for the fourth quarter and year ended December 31, 2023.
BURLINGTON, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, a...
“The thing is watch what they do, not what they say,” Rieder said. “I’ve got to watch more what they say than what they do. Meaning, I don’t think the 75 or the statement are going to be that interesting. And I think they have to tone down the economic section ...
Agilysys, Inc. (NASDAQ: AGYS), a leading global provider of hospitality software solutions that deliver High Return Hospitality, today reported operat
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of forward-looking statements include, but are not limited to, statements, ...
Year-end cash balance of$467.3 millionexpected to fund operations andkey clinical milestones through 2026 SAN FRANCISCO,March 08, 2024(GLOBE NEWSWIRE) --Structure Therapeutics Inc.(NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeut...